WorkupWise
A scheduling and triage tool for oncology clinic admins that sequences each patient's upcoming tests in the most informative order and flags when later tests may be unnecessary based on earlier results.
Oncology clinic operations managers and nurse navigators coordinating diagnostic workups across many patients
- Per-patient test-sequencing recommendations that surface when a downstream test (e.g., genomic profiling) can be deferred or skipped
- Slot-utilization dashboard showing where the clinic is over-ordering relative to peer benchmarks
- Auto-drafted messages to the care team explaining why a test sequence changed
- HIPAA-aligned audit log of every recommendation and the evidence behind it
The same cost-aware, sequential-decision approach that just demonstrated a 55% burden reduction in research can be turned into an operations tool that saves clinics time and money without changing the standard of care.
Multiple established oncology navigation platforms (ONCONav, CONNECT/NurseNav, Azra AI, Navigating Cancer) indicate a sizeable but specialized B2B market; published ROI of ~$485K/yr per navigator program shows real buyer pain.ONCONav Navigation Software | Oncology Data Management ↗The Return on Investment of a Successful Navigation Program ↗
Competitors cover navigation documentation and care coordination, but none explicitly optimize sequential test ordering to cut unnecessary downstream workups — closest analogue SAGEAgent is research-only, not a product.CONNECT: Patient Navigation Software ↗Oncology Navigation Software & Patient Care Coordination | Azra AI ↗SAGEAgent: A Self-Evolving Agent for Cost-Aware Modality Acquisition ↗
Strong willingness to pay: Navigating Cancer lists ~$200-$300/user/month up to $10K-$15K/month for 100 users, and oncology nav programs demonstrably generate hundreds of thousands in net revenue per navigator.Navigating Cancer Pricing 2026 ↗The Return on Investment of a Successful Navigation Program ↗
Cancer incidence is rising, cost-containment pressure on diagnostics is structural, and AI-driven precision oncology CDSS is a well-funded multi-year trend in peer-reviewed literature.The impact of AI on modern oncology from early detection to treatment ↗Artificial intelligence-driven clinical decision support systems for precision oncology ↗
Requires deep clinical validation, EHR integration (FHIR/HL7), likely FDA CDS software oversight, and significant navigator workflow customization; SAGEAgent is a research prototype, not turnkey ops software.SAGEAgent: A Self-Evolving Agent for Cost-Aware Modality Acquisition ↗